Media
Mediabyzbeats

ZBeats Selected by NIH to Exhibit Ambulatory Cardiac Monitoring Technology at VIVE Conference

Nashville, TN – March 26, 2023 — ZBeats, a digital health company advancing scalable solutions in cardiac diagnostics, is pleased to announce its selection by the National Institutes of Health (NIH) to exhibit at the VIVE Conference in Nashville, Tennessee. This sponsorship, extended through the NIH Small Business Innovation Research (SBIR) program, underscores ZBeats’ role in driving innovation in ambulatory ECG analysis and cloud-based diagnostic workflows.

At the conference, ZBeats will present its ZBPro Diagnostic software—an FDA-bound Software as a Medical Device (SaMD) designed to support technician-led ECG interpretation and report generation—as well as its early-stage wearable prototype, ZBPatch, developed to improve long-duration ECG recording for patients in outpatient and remote settings.

“We are proud to represent NIH-funded innovation at one of the industry’s leading health technology events,” said Dr. Bin Fang, CEO and Co-Founder of ZBeats. “This opportunity highlights our commitment to improving diagnostic eViciency and accessibility in cardiac care.”

 

Exhibit Highlights at VIVE 2023:

  • Technology Showcase: Live demonstrations of ZBPro Diagnostic and the betastage ZBPatch will highlight improvements in technician workflows, signal quality review, and scalable diagnostics.
  • SBIR-Driven Development: ZBeats will share outcomes from its NIH-funded research projects, including enhancements in ECG signal processing and long-wear
    device usability.
  • Interactive Engagement: Attendees can explore hands-on use cases and learn how ZBeats’ software platform integrates with electronic health record (EHR) systems and device data sources.
  • Partnership Opportunities: ZBeats welcomes engagement with clinics, IDTFs, research institutions, and digital health partners exploring advanced tools for ambulatory rhythm monitoring.

About ZBeats

ZBeats Inc. is a medical technology company focused on delivering software-driven solutions for ambulatory cardiac diagnostics. Its product suite spans Holter, extended Holter, and mobile cardiac telemetry use cases, with a focus on transparency, clinician oversight, and operational scalability. ZBeats is an NIH SBIR awardee and maintains development operations in New York.

About the NIH SBIR Program

The NIH Small Business Innovation Research (SBIR) program supports early-stage health and life sciences technologies with commercial potential. Its funding enables companies like ZBeats to bring high-impact innovations to market while advancing public health objectives.